Loading…

Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response

Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were...

Full description

Saved in:
Bibliographic Details
Published in:Modern pathology 2022-04, Vol.35 (4), p.462-469
Main Authors: Li, Elizabeth Y., Xu, Jason, Nelson, Nya D., Teachey, David T., Tan, Kai, Romberg, Neil, Behrens, Ed, Pillai, Vinodh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343
cites cdi_FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343
container_end_page 469
container_issue 4
container_start_page 462
container_title Modern pathology
container_volume 35
creator Li, Elizabeth Y.
Xu, Jason
Nelson, Nya D.
Teachey, David T.
Tan, Kai
Romberg, Neil
Behrens, Ed
Pillai, Vinodh
description Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were evaluated from archived formalin-fixed paraffin-embedded lymph node tissue and analyzed by a bioinformatics approach. Differential expression analysis of KFD cases compared to controls revealed 44 significantly upregulated genes in KFD. Sixty-eight percent of these genes were associated with the type I interferon (IFN) response pathway. Key component of the pathway including nucleic acid sensors, IFN regulatory factors, IFN-induced antiviral proteins, IFN transcription factors, IFN-stimulated genes, and IFN-induced cytokines were significantly upregulated. Unbiased gene expression pathway analysis revealed enrichment of IFN signaling and antiviral pathways in KFD. Protein–protein interaction analysis and a molecular complex detection algorithm identified a densely interacting 15-gene module of type I IFN pathway genes. Apoptosis regulator IFI6 was identified as a key seed gene. Transcription factor target analysis identified enrichment of IFN-response elements and IFN-response factors. T-cell-associated genes were upregulated while myeloid and B-cell-associated genes were downregulated in KFD. CD123+ plasmacytoid dendritic cells (PDCs) and activated T cells were noted in KFD. In conclusion, KFD is mediated by an aberrant type I interferon response that is likely driven by PDCs and T cells.
doi_str_mv 10.1038/s41379-021-00992-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2614234041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2614234041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxiQJRaWgO2zk3hEFYWKCpbultNcwKX5wE6G_ntcyofEwC0nnZ97z3oIOefsmjPIb4LkkOmECZ4wprVIsgMy5gpYHOXqkIxZriEBrcSInISwZoxLlYtjMgIZh1rKMXl6dG_D6tUls2Ht6rZvaekC2oDUBVpj6WyPJS221DbUFui9bXrabzukc-qaHn2Fvm2ox9C1TcBTclTZTcCzrz4hy9ndcvqQLJ7v59PbRbKSXPeJRpZpW2heQRpLpTYDSDMFhQWRM5kLAZjmAspKoWKIPLVWllAJxTRImJCrfWzn2_cBQ29qF1a42dgG2yEYkXIpQLIoaEIu_6DrdvBN_FykpFRaZpBFSuyplW9D8FiZzrva-q3hzOxkm71sE2WbT9lmt3TxFT0UUdXPyrfdCMAeCPGpeUH_e_uf2A_5G4gI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644594737</pqid></control><display><type>article</type><title>Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response</title><source>Nature_系列刊</source><creator>Li, Elizabeth Y. ; Xu, Jason ; Nelson, Nya D. ; Teachey, David T. ; Tan, Kai ; Romberg, Neil ; Behrens, Ed ; Pillai, Vinodh</creator><creatorcontrib>Li, Elizabeth Y. ; Xu, Jason ; Nelson, Nya D. ; Teachey, David T. ; Tan, Kai ; Romberg, Neil ; Behrens, Ed ; Pillai, Vinodh</creatorcontrib><description>Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were evaluated from archived formalin-fixed paraffin-embedded lymph node tissue and analyzed by a bioinformatics approach. Differential expression analysis of KFD cases compared to controls revealed 44 significantly upregulated genes in KFD. Sixty-eight percent of these genes were associated with the type I interferon (IFN) response pathway. Key component of the pathway including nucleic acid sensors, IFN regulatory factors, IFN-induced antiviral proteins, IFN transcription factors, IFN-stimulated genes, and IFN-induced cytokines were significantly upregulated. Unbiased gene expression pathway analysis revealed enrichment of IFN signaling and antiviral pathways in KFD. Protein–protein interaction analysis and a molecular complex detection algorithm identified a densely interacting 15-gene module of type I IFN pathway genes. Apoptosis regulator IFI6 was identified as a key seed gene. Transcription factor target analysis identified enrichment of IFN-response elements and IFN-response factors. T-cell-associated genes were upregulated while myeloid and B-cell-associated genes were downregulated in KFD. CD123+ plasmacytoid dendritic cells (PDCs) and activated T cells were noted in KFD. In conclusion, KFD is mediated by an aberrant type I interferon response that is likely driven by PDCs and T cells.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/s41379-021-00992-7</identifier><identifier>PMID: 34952944</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>13/51 ; 38/39 ; 38/91 ; 631/208/199 ; 692/699/1541 ; Antiviral Agents ; Apoptosis ; Autoimmunity ; Bioinformatics ; CD123 antigen ; Dendritic cells ; Etiology ; Gene expression ; Histiocytic Necrotizing Lymphadenitis - diagnosis ; Histiocytic Necrotizing Lymphadenitis - genetics ; Histiocytic Necrotizing Lymphadenitis - pathology ; Humans ; Interferon ; Interferon Type I - genetics ; Laboratory Medicine ; Lymph nodes ; Lymph Nodes - pathology ; Lymphadenitis ; Lymphadenitis - pathology ; Lymphatic diseases ; Lymphocytes B ; Lymphocytes T ; Medicine ; Medicine &amp; Public Health ; Paraffin ; Pathology ; Regulatory sequences ; Transcription factors</subject><ispartof>Modern pathology, 2022-04, Vol.35 (4), p.462-469</ispartof><rights>The Author(s), under exclusive licence to United States &amp; Canadian Academy of Pathology 2021</rights><rights>2021. The Author(s), under exclusive licence to United States &amp; Canadian Academy of Pathology.</rights><rights>The Author(s), under exclusive licence to United States &amp; Canadian Academy of Pathology 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343</citedby><cites>FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343</cites><orcidid>0000-0001-7126-6226</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34952944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Elizabeth Y.</creatorcontrib><creatorcontrib>Xu, Jason</creatorcontrib><creatorcontrib>Nelson, Nya D.</creatorcontrib><creatorcontrib>Teachey, David T.</creatorcontrib><creatorcontrib>Tan, Kai</creatorcontrib><creatorcontrib>Romberg, Neil</creatorcontrib><creatorcontrib>Behrens, Ed</creatorcontrib><creatorcontrib>Pillai, Vinodh</creatorcontrib><title>Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were evaluated from archived formalin-fixed paraffin-embedded lymph node tissue and analyzed by a bioinformatics approach. Differential expression analysis of KFD cases compared to controls revealed 44 significantly upregulated genes in KFD. Sixty-eight percent of these genes were associated with the type I interferon (IFN) response pathway. Key component of the pathway including nucleic acid sensors, IFN regulatory factors, IFN-induced antiviral proteins, IFN transcription factors, IFN-stimulated genes, and IFN-induced cytokines were significantly upregulated. Unbiased gene expression pathway analysis revealed enrichment of IFN signaling and antiviral pathways in KFD. Protein–protein interaction analysis and a molecular complex detection algorithm identified a densely interacting 15-gene module of type I IFN pathway genes. Apoptosis regulator IFI6 was identified as a key seed gene. Transcription factor target analysis identified enrichment of IFN-response elements and IFN-response factors. T-cell-associated genes were upregulated while myeloid and B-cell-associated genes were downregulated in KFD. CD123+ plasmacytoid dendritic cells (PDCs) and activated T cells were noted in KFD. In conclusion, KFD is mediated by an aberrant type I interferon response that is likely driven by PDCs and T cells.</description><subject>13/51</subject><subject>38/39</subject><subject>38/91</subject><subject>631/208/199</subject><subject>692/699/1541</subject><subject>Antiviral Agents</subject><subject>Apoptosis</subject><subject>Autoimmunity</subject><subject>Bioinformatics</subject><subject>CD123 antigen</subject><subject>Dendritic cells</subject><subject>Etiology</subject><subject>Gene expression</subject><subject>Histiocytic Necrotizing Lymphadenitis - diagnosis</subject><subject>Histiocytic Necrotizing Lymphadenitis - genetics</subject><subject>Histiocytic Necrotizing Lymphadenitis - pathology</subject><subject>Humans</subject><subject>Interferon</subject><subject>Interferon Type I - genetics</subject><subject>Laboratory Medicine</subject><subject>Lymph nodes</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphadenitis</subject><subject>Lymphadenitis - pathology</subject><subject>Lymphatic diseases</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Paraffin</subject><subject>Pathology</subject><subject>Regulatory sequences</subject><subject>Transcription factors</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwBxiQJRaWgO2zk3hEFYWKCpbultNcwKX5wE6G_ntcyofEwC0nnZ97z3oIOefsmjPIb4LkkOmECZ4wprVIsgMy5gpYHOXqkIxZriEBrcSInISwZoxLlYtjMgIZh1rKMXl6dG_D6tUls2Ht6rZvaekC2oDUBVpj6WyPJS221DbUFui9bXrabzukc-qaHn2Fvm2ox9C1TcBTclTZTcCzrz4hy9ndcvqQLJ7v59PbRbKSXPeJRpZpW2heQRpLpTYDSDMFhQWRM5kLAZjmAspKoWKIPLVWllAJxTRImJCrfWzn2_cBQ29qF1a42dgG2yEYkXIpQLIoaEIu_6DrdvBN_FykpFRaZpBFSuyplW9D8FiZzrva-q3hzOxkm71sE2WbT9lmt3TxFT0UUdXPyrfdCMAeCPGpeUH_e_uf2A_5G4gI</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Li, Elizabeth Y.</creator><creator>Xu, Jason</creator><creator>Nelson, Nya D.</creator><creator>Teachey, David T.</creator><creator>Tan, Kai</creator><creator>Romberg, Neil</creator><creator>Behrens, Ed</creator><creator>Pillai, Vinodh</creator><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7126-6226</orcidid></search><sort><creationdate>20220401</creationdate><title>Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response</title><author>Li, Elizabeth Y. ; Xu, Jason ; Nelson, Nya D. ; Teachey, David T. ; Tan, Kai ; Romberg, Neil ; Behrens, Ed ; Pillai, Vinodh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>13/51</topic><topic>38/39</topic><topic>38/91</topic><topic>631/208/199</topic><topic>692/699/1541</topic><topic>Antiviral Agents</topic><topic>Apoptosis</topic><topic>Autoimmunity</topic><topic>Bioinformatics</topic><topic>CD123 antigen</topic><topic>Dendritic cells</topic><topic>Etiology</topic><topic>Gene expression</topic><topic>Histiocytic Necrotizing Lymphadenitis - diagnosis</topic><topic>Histiocytic Necrotizing Lymphadenitis - genetics</topic><topic>Histiocytic Necrotizing Lymphadenitis - pathology</topic><topic>Humans</topic><topic>Interferon</topic><topic>Interferon Type I - genetics</topic><topic>Laboratory Medicine</topic><topic>Lymph nodes</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphadenitis</topic><topic>Lymphadenitis - pathology</topic><topic>Lymphatic diseases</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Paraffin</topic><topic>Pathology</topic><topic>Regulatory sequences</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Elizabeth Y.</creatorcontrib><creatorcontrib>Xu, Jason</creatorcontrib><creatorcontrib>Nelson, Nya D.</creatorcontrib><creatorcontrib>Teachey, David T.</creatorcontrib><creatorcontrib>Tan, Kai</creatorcontrib><creatorcontrib>Romberg, Neil</creatorcontrib><creatorcontrib>Behrens, Ed</creatorcontrib><creatorcontrib>Pillai, Vinodh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Elizabeth Y.</au><au>Xu, Jason</au><au>Nelson, Nya D.</au><au>Teachey, David T.</au><au>Tan, Kai</au><au>Romberg, Neil</au><au>Behrens, Ed</au><au>Pillai, Vinodh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>35</volume><issue>4</issue><spage>462</spage><epage>469</epage><pages>462-469</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><abstract>Kikuchi-Fujimoto disease (KFD) is a reactive lymphadenitis of unclear etiology. To understand the pathogenesis of KFD, we performed targeted RNA sequencing of a well-characterized cohort of 15 KFD specimens with 9 non-KFD lymphadenitis controls. Two thousand and three autoimmunity-related genes were evaluated from archived formalin-fixed paraffin-embedded lymph node tissue and analyzed by a bioinformatics approach. Differential expression analysis of KFD cases compared to controls revealed 44 significantly upregulated genes in KFD. Sixty-eight percent of these genes were associated with the type I interferon (IFN) response pathway. Key component of the pathway including nucleic acid sensors, IFN regulatory factors, IFN-induced antiviral proteins, IFN transcription factors, IFN-stimulated genes, and IFN-induced cytokines were significantly upregulated. Unbiased gene expression pathway analysis revealed enrichment of IFN signaling and antiviral pathways in KFD. Protein–protein interaction analysis and a molecular complex detection algorithm identified a densely interacting 15-gene module of type I IFN pathway genes. Apoptosis regulator IFI6 was identified as a key seed gene. Transcription factor target analysis identified enrichment of IFN-response elements and IFN-response factors. T-cell-associated genes were upregulated while myeloid and B-cell-associated genes were downregulated in KFD. CD123+ plasmacytoid dendritic cells (PDCs) and activated T cells were noted in KFD. In conclusion, KFD is mediated by an aberrant type I interferon response that is likely driven by PDCs and T cells.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>34952944</pmid><doi>10.1038/s41379-021-00992-7</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7126-6226</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2022-04, Vol.35 (4), p.462-469
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_miscellaneous_2614234041
source Nature_系列刊
subjects 13/51
38/39
38/91
631/208/199
692/699/1541
Antiviral Agents
Apoptosis
Autoimmunity
Bioinformatics
CD123 antigen
Dendritic cells
Etiology
Gene expression
Histiocytic Necrotizing Lymphadenitis - diagnosis
Histiocytic Necrotizing Lymphadenitis - genetics
Histiocytic Necrotizing Lymphadenitis - pathology
Humans
Interferon
Interferon Type I - genetics
Laboratory Medicine
Lymph nodes
Lymph Nodes - pathology
Lymphadenitis
Lymphadenitis - pathology
Lymphatic diseases
Lymphocytes B
Lymphocytes T
Medicine
Medicine & Public Health
Paraffin
Pathology
Regulatory sequences
Transcription factors
title Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T09%3A16%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kikuchi-Fujimoto%20disease%20is%20mediated%20by%20an%20aberrant%20type%20I%20interferon%20response&rft.jtitle=Modern%20pathology&rft.au=Li,%20Elizabeth%20Y.&rft.date=2022-04-01&rft.volume=35&rft.issue=4&rft.spage=462&rft.epage=469&rft.pages=462-469&rft.issn=0893-3952&rft.eissn=1530-0285&rft_id=info:doi/10.1038/s41379-021-00992-7&rft_dat=%3Cproquest_cross%3E2614234041%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-9e079ab91f3666656a7336753ba328048223e6823df5e50ee16aa4d3f2509343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2644594737&rft_id=info:pmid/34952944&rfr_iscdi=true